Executive Clinical Snapshot
Prof. Lunxu Liu, MD, PhD, is the Executive Vice President of West China Hospital, Sichuan University, and Director of the Institute of Thoracic Oncology. Nationally recognized and internationally acclaimed, Prof. Liu is widely regarded as one of the world's most influential pioneers in minimally invasive thoracic surgery. He revolutionized global thoracic oncology by developing and popularizing Single-Direction Video-Assisted Thoracoscopic Surgery (VATS) Lobectomy—frequently referred to in international surgical literature as "Liu's Technique." This procedural paradigm shifts complex anatomical resections from multi-angle, high-manipulation interventions into an orderly, forward-progressing, low-traction sequence, drastically decreasing intraoperative hemorrhage risks and operative duration while setting benchmark standards for oncologic radicality.
Academic Leadership & Institutional Standing
- Executive Vice President, West China Hospital, Sichuan University (consistently ranked in China's top tier of clinical academic medical centers).
- Director, Institute of Thoracic Oncology, West China Hospital of Sichuan University.
- President / Vice President, Chinese Association of Thoracic Surgeons (CATS).
- Council Member & International Fellow, American Association for Thoracic Surgery (AATS) and European Society of Thoracic Surgeons (ESTS).
- Deputy Director, Minimally Invasive Surgery Committee of the Chinese Medical Doctor Association.
- Principal Investigator & National Lead for key national research initiatives focusing on robotic thoracic surgery, sublobar lung resections, and perioperative immuno-oncology combinations.
Surgical Breakthrough: The Single-Direction VATS Paradigm
Before Prof. Liu's innovation, conventional thoracoscopic lobectomy required continuous flipping, repositioning, and pulling of lung lobes to dissect the pulmonary hilum from various angles. In patients with dense pleural adhesions, incomplete interlobar fissures, or friable pulmonary vessels, traditional methods presented substantial risks of catastrophic vascular avulsion and prolonged air leaks.
Core Pillars of Liu's Single-Direction Technique:
- Sequential Anterior-to-Posterior Dissection: Surgical dissection proceeds systematically along a single visual and anatomical plane without turning the pulmonary lobe back and forth, significantly minimizing vascular trauma and lung tissue injury.
- Fissure-Last & Fissureless Approaches: Eliminates the traditional prerequisite of dissecting through deep, inflammatory, or undeveloped interlobar fissures, reducing post-operative air leaks by up to 60%.
- Standardized Radical Lymphadenectomy: Standardized en bloc mediastinal and hilar lymph node clearance protocols under video-assisted magnifications, ensuring strict adherence to international NCCN oncologic margins.
- Adaptability across Multi-Port, Uniportal, and Robotic Platforms: The foundational logic of single-direction dissection translates seamlessly into uniportal VATS (single-port access through an incision of just 2.5–3.5 cm) as well as modern robotic-assisted thoracic surgical platforms (RATS).
Comprehensive Surgical Spectrum & Specialized Focus
- Minimally Invasive Anatomical Resections: Single-direction VATS and uniportal lobectomy, anatomical segmentectomy, and multi-subsegmentectomy for early-stage peripheral non-small cell lung cancer (NSCLC) and ground-glass nodules (GGNs).
- Complex & Central Lung Tumors: Thoracoscopic bronchial sleeve lobectomy, double-sleeve (bronchial and pulmonary arterial) reconstructions, and carina-sparing resections for centrally located tumors, sparing patients from total pneumonectomy.
- Tracheal & Mediastinal Surgery: Radical resection of anterior, middle, and posterior mediastinal tumors (thymomas, neurogenic tumors, and germ cell neoplasms) via subxiphoid or uniportal thoracoscopy, avoiding sternotomy.
- Sublobar Resection & Pulmonary Function Preservation: 3D-CT bronchovascular reconstruction-guided precise anatomical segmentectomy for patients with compromised baseline pulmonary reserve or multiple synchronous primary lung nodules.
- Locally Advanced Thoracic Oncology: Salvage resections and multimodality consolidation surgery following neoadjuvant targeted therapy or chemo-immunotherapy downstaging.
High-Complexity Benchmark Scenarios
Scenario A: Central Squamous Cell Carcinoma Requiring Bronchial Sleeve Resection
A 58-year-old male presented with endobronchial obstruction of the right upper lobe bronchus abutting the main bronchus. Conventional surgery would have dictated a complete right-sided pneumonectomy with severe long-term disability. Prof. Liu's surgical team completed a complete thoracoscopic right upper lobe sleeve lobectomy, meticulously anastomosing the intermediate bronchus directly to the right main bronchus. Clear margins (R0) were achieved with complete lung parenchyma preservation, and the patient was safely discharged within six days.
Scenario B: Uniportal VATS Segmentectomy for Deep-Seated Ground-Glass Nodule (GGN)
A 44-year-old female with an isolated 12 mm pure ground-glass nodule located deep within the posterior basal segment of the left lower lobe (LS10). Utilizing preoperative 3D pulmonary artery and bronchus reconstruction, Prof. Liu executed a flawless uniportal VATS LS10 segmentectomy through a single 3 cm intercostal incision. Pathological evaluation confirmed non-invasive adenocarcinoma in situ with negative resection margins and zero functional compromise.
Global Educational Footprint & Scientific Leadership
Prof. Liu's surgical techniques and instructional videos have been featured in top surgical associations worldwide, including live demonstration broadcasts at AATS and ESTS annual meetings. Thoracic surgeons from Europe, North America, and across the Asia-Pacific region have trained at West China Hospital to master his single-direction method. With over 200 high-impact peer-reviewed publications across The Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, The Lancet Oncology, and Chest, his scientific and surgical legacy has shaped international clinical guidelines for thoracic oncology.
International Patient Access & Clinical Coordination
Cross-border patients diagnosed with pulmonary nodules, mediastinal lesions, or advanced thoracic malignancies can coordinate direct access to Prof. Lunxu Liu's specialized surgical team at West China Hospital via China Medical Concierge – Shanghai (CMCS):
- Comprehensive Imaging & DICOM Re-evaluation: Sub-millimeter thin-slice thoracic CT review and expert multidisciplinary surgical feasibility assessment before international travel.
- Virtual Pre-Travel Surgical Consultation: Video or comprehensive written surgical evaluation addressing candidacy for uniportal VATS, parenchymal-sparing segmentectomy, or sleeve resection.
- Priority Inpatient Admission & Operating Theater Scheduling: Expedited surgical booking at West China Hospital's specialized thoracic surgical suites, bypassing general administrative waitlists.
- Bilingual Medical Escort & Perioperative Support: Dedicated bilingual clinical case managers guiding patients through pulmonary rehabilitation, bedside communication, pain management, and pathology debriefs.
- Long-Term Follow-up & Restaging Protocols: Seamless continuity of care, digital CT surveillance transmission, and cross-border coordination with local treating oncologists.
Connect with CMCS Medical Concierge
For confidential clinical inquiries, medical record reviews, or to schedule a surgical evaluation with Prof. Lunxu Liu:
Email: contract@medicalsh.com
WhatsApp: Connect on WhatsApp
Official Website: www.medicalsh.com
댓글 0개